Avestar Capital’s iShares Global Healthcare ETF IXJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-3,531
Closed -$270K 330
2020
Q4
$270K Sell
3,531
-417
-11% -$30.7K 0.08% 227
2020
Q3
$282K Sell
3,948
-21,779
-85% -$1.56M 0.09% 166
2020
Q2
$1.77M Buy
25,727
+1,446
+6% +$97.6K 0.78% 25
2020
Q1
$1.48M Buy
24,281
+2,074
+9% +$137K 0.81% 25
2019
Q4
$1.53M Sell
22,207
-921
-4% -$59.7K 0.86% 23
2019
Q3
$1.41M Buy
23,128
+114
+0.5% +$6.97K 0.88% 24
2019
Q2
$1.4M Buy
23,014
+1,355
+6% +$81.2K 0.89% 22
2019
Q1
$1.3M Sell
21,659
-5,016
-19% -$299K 0.85% 24
2018
Q4
$1.5M Buy
+26,675
New +$1.6M 1.02% 23

Other funds holding IXJ

Avestar Capital's IXJ Position: Q1 2021 in Review

Avestar Capital sold out of iShares Global Healthcare ETF (IXJ) in Q1 2021, closing a stake of 3,531 shares — an estimated $270K sold.

Avestar Capital first reported a position in IXJ in Q4 2018 and held it in 9 quarters. The position peaked at $1.77M in Q2 2020. 205 funds tracked by Wall St. Rank hold IXJ as of Q1 2021.

  • Avestar Capital reported no remaining iShares Global Healthcare ETF position as of Q1 2021 after selling out during the quarter.
  • Avestar Capital sold 3,531 iShares Global Healthcare ETF shares in Q1 2021, an estimated $270K.
  • Avestar Capital first reported a position in iShares Global Healthcare ETF in Q4 2018 and held it in 9 quarters.
  • Avestar Capital's iShares Global Healthcare ETF position peaked at $1.77M in Q2 2020.
  • 205 funds tracked by Wall St. Rank held iShares Global Healthcare ETF as of Q1 2021.

Based on Avestar Capital's 13F filing for Q1 2021, filed 3 May 2021.